Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Robot-Assisted Distal Ureterectomy Versus Nephroureterectomy in Urothelial Carcinoma
1
Mins
May 2024
Patients with high-risk upper tract urothelial carcinoma (UTUC) typically undergo radical nephroureterectomy (RNU)…
Read more
1
Mins
16th May 2024
Robot-Assisted Distal Ureterectomy Versus Nephroureterectomy in Urothelial Carcinoma
Patients with high-risk upper tract urothelial carcinoma (UTUC) typically undergo radical nephroureterectomy (RNU)…
1
Mins
16th May 2024
Scoring System Predicts Need for Intervention for Non-Muscle Invasive Bladder Cancer Patients
Patients with low-grade (LG) Ta non-muscle invasive bladder cancer (NMIBC) exhibit a high recurrence rate, while cancer-specific…
1
Mins
16th May 2024
Twenty-Year Follow-Up of Large-Volume Low-Grade Urothelial Carcinoma
According to the European Association of Urology (EAU) Guidelines, tumour size exceeding 2 cm serves as a crucial factor…
1
Mins
16th May 2024
Buccal Mucosa Graft Urethroplasty With or Without Meatus Reconstruction
Approximately 15–20% of patients who undergo urethroplasty (UP) with buccal mucosa graft (BMG) will suffer urethral stricture recurrence…
10
Mins
16th May 2024
EAU 2024 Abstract Highlights
PROSTATE-specific membrane antigen (PSMA)-PET imaging can influence decision-making in prostate cancer, improving survival outcomes…
1
Mins
20th April 2023
⁶⁸Ga-Prostate-Specific Membrane Antigen PET Radiomics For the Prediction of Post-Surgical International Society of Urological Pathology Grade in Patients with Primary Prostate Cancer
Radiomics has been proven effective for the characterisation of primary prostate cancer (PCa).1,2 However, the limited interpretability of the proposed models represents one of the major limitations in this field.
2
Mins
20th April 2023
SuPARnostic: An Advanced Predictive Tool for Detecting Recurrence in Renal Cell Carcinoma
Renal cell carcinoma (RCC) is the most common malignant kidney tumour, with clear cell RCC (ccRCC) accounting for 70–80% of all cases. Approximately 15–20% of patients have primary metastatic RCC at diagnosis, and 15–20% of those who receive curative treatment for localised tumours will experience recurrence within 5 years of follow-up.
2
Mins
20th April 2023
Genomic Profiling of Urothelial Carcinoma
in Situ
of the Bladder
Urothelial carcinoma in situ (CIS) of the bladder is an intra-epithelial, high grade, malignant neoplasm characterised by flat (non-papillary) growth, with high probability of disease progression.
Loading posts...
1
2
3
…
10
Next »